Q: How is the complete lung cancer organoid medium prepared?

The complete culture medium is prepared by mixing 96 mL human lung cancer organoid basal medium A with 4 mL human lung cancer organoid culture supplement B.

Q: How should Biofargo Human Lung Cancer Organoid Culture Kit be stored?

Human lung cancer organoid basal medium A can be stored at 4°C for 3 months or -20°C for 12 months. Culture supplement B should be stored at -20°C for 6 months.

What type of organoid model can be cultured with this lung cancer organoid medium?

This lung cancer organoid culture system is designed for human lung cancer tissue-derived organoid culture, including patient-derived lung cancer organoid research workflows.

Does Biofargo Human Lung Cancer Organoid Culture Kit support patient-derived tumor organoid research?

Yes. The kit is designed to support patient-derived lung cancer organoid establishment and expansion, providing a 3D tumor model platform for experimental cancer research.

Can lung cancer organoids be used for drug screening studies?

Yes. Human lung cancer organoids can be used as a 3D tumor research platform for experimental drug screening and response evaluation studies.

What research applications are supported by this lung tumor organoid culture system?

Applications include lung cancer disease modeling, tumor biology studies, cancer drug screening, precision oncology research, and development of patient-specific tumor models.

Is Biofargo Human Lung Cancer Organoid Culture Kit intended for clinical use?

No. This product is intended for research use only and is not designed for clinical diagnosis or therapeutic applications.

Description

Establishing reliable human lung cancer organoid models from primary tumor tissues can be challenging due to variations in tumor samples, limited expansion capacity, and the difficulty of maintaining tumor-specific characteristics during in vitro culture. Researchers often require a standardized culture environment that supports consistent organoid establishment while preserving the biological relevance of patient-derived tumor models.

Biofargo Human Lung Cancer Organoid Culture Kit (BiofargohLungCO-100) is a specialized lung tumor organoid culture system designed for the generation, expansion, and maintenance of human lung cancer organoids derived from tumor tissues. The kit provides a standardized culture solution consisting of human lung cancer organoid basal medium A and culture supplement B, enabling researchers to prepare a complete organoid culture medium for 3D tumor model development.

This human lung cancer organoid culture kit supports patient-derived lung cancer organoid research workflows, including tumor biology studies, disease modeling, cancer drug screening, and precision oncology research. By providing a defined culture environment, Biofargo organoid medium helps researchers establish reproducible 3D lung cancer models for advanced cancer research applications.

Specifications

Product Name	Biofargo Human Lung Cancer Organoid Culture Kit
SKU	BiofargohLungCO-100
Product Type	Human lung cancer organoid culture medium kit
Application Model	Patient-derived lung cancer organoid culture and 3D tumor model research
Components	Human Lung Cancer Organoid Basal Medium A Human Lung Cancer Organoid Culture Supplement B
Basal Medium Volume	96 mL
Culture Supplement Volume	4 mL
Prepared Complete Medium	100 mL after mixing basal medium A with supplement B
Basal Medium Storage	4°C for 3 months; -20°C for 12 months
Supplement Storage	-20°C for 6 months
Culture Format	3D extracellular matrix-based organoid culture
Research Use	Research Use Only (RUO)

Features

Dedicated Human Lung Cancer Organoid Culture System — Designed specifically for human lung cancer tissue-derived organoid establishment and expansion workflows.
Supports Patient-Derived Lung Cancer Organoid Research — Provides a standardized culture environment for developing clinically relevant 3D tumor models.
Ready-to-Prepare Complete Organoid Medium — Combine basal medium A with culture supplement B to prepare complete lung cancer organoid medium.
Supports 3D Tumor Model Development — Enables researchers to establish three-dimensional lung cancer models for downstream research applications.
Suitable for Cancer Drug Screening Studies — Supports organoid-based evaluation workflows for investigating tumor responses under experimental conditions.
Standardized Culture Performance — A defined workflow helps improve experimental consistency between organoid culture experiments.
Supports Long-Term Organoid Expansion Research — The cultured organoids can maintain expansion capability for multiple passages according to experimental conditions.

Human Lung Cancer Organoid Culture Workflow

The establishment of patient-derived lung cancer organoids typically requires efficient tissue processing, controlled dissociation, extracellular matrix embedding, and specialized organoid culture conditions. Biofargo Human Lung Cancer Organoid Culture Kit is designed to support a standardized workflow from primary tumor tissue preparation to 3D organoid expansion.

Step 1: Tumor Tissue Collection and Preservation

Freshly isolated lung cancer tissue samples are temporarily preserved in pre-cooled primary tissue storage solution and maintained under refrigerated conditions before processing.

Step 2: Tissue Washing and Mechanical Processing

Under sterile conditions, tumor tissues are washed repeatedly with pre-cooled PBS to remove residual impurities. Clean tissues are then transferred into sterile tubes and mechanically cut into small tissue fragments approximately 1–3 mm³ in size.

Step 3: Tissue Dissociation and Cell Preparation

Prepared tissue fragments are treated with primary tissue digestion solution at 37°C for approximately 15–45 minutes depending on tissue source and size. Following digestion, the cell suspension is filtered through a 100 μm cell strainer to remove undigested tissue fragments.

Step 4: Organoid Embedding and 3D Culture Initiation

Collected cells are mixed with extracellular matrix material at an optimized density range of 1×10⁵–1×10⁶ cells/mL. Cell-matrix droplets are placed into culture plates and incubated at 37°C with 5% CO₂ until matrix solidification.

Step 5: Lung Cancer Organoid Expansion

After matrix solidification, complete lung cancer organoid culture medium prepared from basal medium A and supplement B is added around the matrix dome. Organoids are maintained under standard cell culture conditions for establishment and expansion.

Workflow Stage	Key Process
Tissue Preparation	Primary lung cancer tissue washing and fragmentation
Cell Isolation	Enzymatic dissociation and filtration
3D Matrix Culture	Cell embedding and extracellular matrix-supported growth
Organoid Expansion	Culture maintenance using complete lung cancer organoid medium

Applications

Biofargo Human Lung Cancer Organoid Culture Kit is designed for researchers developing patient-derived lung cancer organoid models and performing advanced 3D tumor research. Compared with traditional two-dimensional cancer cell culture models, lung cancer organoids provide a more physiologically relevant platform for studying tumor characteristics, treatment responses, and disease mechanisms.

Patient-Derived Lung Cancer Organoid Establishment

The kit supports the generation of lung cancer organoids from primary tumor tissues, providing researchers with a practical approach for establishing patient-derived tumor models for experimental studies.

Lung cancer organoid culture — Establish and maintain three-dimensional lung tumor organoid models from tumor-derived samples.
Patient-derived cancer model development — Generate experimental models that better represent individual tumor characteristics compared with conventional cell lines.

Lung Cancer Disease Modeling

Human lung cancer organoids can be used as advanced in vitro models for investigating tumor growth characteristics, biological mechanisms, and interactions within controlled experimental environments.

Tumor biology research — Study lung cancer-related cellular behaviors and experimental responses.
Cancer mechanism studies — Support investigations involving tumor development and progression pathways.
3D lung cancer model research — Provide a three-dimensional platform for cancer biology studies.

Cancer Drug Screening and Response Evaluation

Patient-derived lung cancer organoids provide a valuable platform for evaluating experimental drug responses. Researchers can apply organoid-based screening approaches to compare treatment effects under controlled laboratory conditions.

Lung cancer drug screening
Anticancer compound evaluation
Personalized treatment research

Precision Oncology Research

Patient-derived organoid models are increasingly used in precision oncology research because they can help researchers investigate differences between tumor samples and evaluate experimental treatment strategies.

Precision medicine research
Patient-specific tumor model development
Translational cancer research

Why Choose Biofargo Human Lung Cancer Organoid Culture Kit?

Traditional lung cancer research models based on immortalized cell lines may not fully represent the complexity and heterogeneity of primary tumors. Researchers working on advanced cancer models require culture systems that support reproducible organoid establishment and long-term experimental workflows.

Biofargo Human Lung Cancer Organoid Culture Kit provides a dedicated lung tumor organoid medium system designed for researchers performing 3D cancer model development. The standardized formulation simplifies preparation while supporting organoid establishment, expansion, and downstream research applications including disease modeling and drug screening.

Research Challenge	Biofargo Solution
Difficulty establishing lung cancer organoid models	Dedicated human lung cancer organoid culture medium system
Variation between experimental workflows	Standardized basal medium and supplement combination
Need for clinically relevant tumor models	Supports patient-derived lung cancer organoid research
Limited application of 2D cancer models	Enables 3D tumor organoid culture approaches

FAQ

What is Biofargo Human Lung Cancer Organoid Culture Kit used for?

Biofargo Human Lung Cancer Organoid Culture Kit is a specialized culture system designed for human lung cancer organoid establishment and expansion. It supports researchers developing patient-derived lung cancer organoid models for 3D tumor research, disease modeling, and cancer drug screening applications.

What type of samples are suitable for this lung cancer organoid culture system?

The product is designed for research workflows involving human lung cancer tissue-derived samples. Researchers can use this system to establish three-dimensional lung tumor organoid models under controlled culture conditions.

Does this product support patient-derived lung cancer organoid (PDO) research?

Yes. Biofargo Human Lung Cancer Organoid Culture Kit is designed to support patient-derived lung cancer organoid research by providing a standardized culture environment for tumor organoid establishment and expansion.

What are the main applications of human lung cancer organoids?

Human lung cancer organoids can be used for multiple research applications, including lung cancer disease modeling, tumor biology studies, cancer drug screening, anticancer compound evaluation, and precision oncology research.

How is the complete lung cancer organoid medium prepared?

The complete medium is prepared by combining 96 mL of human lung cancer organoid basal medium A with 4 mL of human lung cancer organoid culture supplement B. After mixing thoroughly, the prepared medium can be used for lung cancer organoid culture workflows.

Can this kit be used for 3D tumor model development?

Yes. The kit is designed for three-dimensional lung cancer organoid culture and supports the development of 3D tumor models for experimental oncology research.

How long can lung cancer organoids be expanded using this system?

According to product evaluation data, cultured organoids can maintain expansion capability for at least 3 passages, and some organoid cultures may achieve more than 10 passages depending on sample characteristics and experimental conditions.

How should the product components be stored?

Human lung cancer organoid basal medium A should be stored at 4°C or -20°C depending on storage duration. Human lung cancer organoid culture supplement B should be stored at -20°C. Avoid repeated freeze-thaw cycles.

Is Biofargo Human Lung Cancer Organoid Culture Kit suitable for clinical diagnosis or treatment?

No. Biofargo Human Lung Cancer Organoid Culture Kit is intended for research use only (RUO). It is not approved for clinical diagnostic or therapeutic applications.

Research Use Statement

Biofargo Human Lung Cancer Organoid Culture Kit is intended for laboratory research applications only. This product is designed to support human lung cancer organoid culture, 3D tumor model development, cancer biology research, and related experimental studies. It is not intended for use in clinical diagnosis, prevention, or treatment.

Human Lung Cancer Organoid Medium Kit